Athanase Innovation AB
Athanase Innovation AB operates in the financial services sector, providing banking and investment services, primarily through its operations in the capital markets.
Business. Athanase Innovation AB (ATHAN.ST) is a financial services provider operating within the Banking & Investment Services sector, specifically engaged in financial and commodity market operations. The company is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. As specific segment and geographic breakdowns are not provided, the firm is characterized at the industry level as a fee-income-based service provider.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Athanase Innovation AB (ATHAN.ST) is a financial services provider operating within the Banking & Investment Services sector, specifically engaged in financial and commodity market operations. The company is headquartered in Sweden and is primarily listed on the Nasdaq Stockholm exchange. As specific segment and geographic breakdowns are not provided, the firm is characterized at the industry level as a fee-income-based service provider.
Athanase Innovation AB maintains a strong liquidity position, as evidenced by a current ratio of 6.03, indicating that the company has sufficient current assets to cover its current liabilities multiple times over. The company's liquidity is further supported by a debt-to-equity ratio of 0.0, suggesting that it is not reliant on debt financing and has a strong equity base. However, the company's operating cash flow is negative at -10.622 million SEK, which may raise concerns about its ability to generate cash from operations.
In terms of profitability, Athanase Innovation AB reports a net income of 23.389 million SEK and an operating income of 23.356 million SEK, indicating a healthy performance in the current fiscal year. The company's return on equity (ROE) is 3.56%, and its return on assets (ROA) is 3.13%, both of which are below the industry median for capital markets firms, suggesting that the company may not be as efficient in generating returns on its equity and assets as its peers.
The company's revenue is concentrated in a single segment, as no specific segments are disclosed in the available data. Geographically, the company's exposure is not detailed, but the absence of segment or geographic breakdowns implies that the company may not have a diversified revenue base. This lack of diversification could pose a risk if the company's primary market experiences a downturn.
Looking ahead, the company's growth trajectory is not explicitly outlined in the available data. However, the company's free cash flow of 26.72 million SEK suggests that it has the capacity to reinvest in its operations or return value to shareholders. The absence of detailed outlook data for the next fiscal year makes it difficult to assess the company's future performance with certainty.
The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt indicates that the company's cash reserves are insufficient to cover its debt obligations. However, the low dilution risk suggests that the company is not expected to issue additional shares in the near term, which could help maintain shareholder value.
Recent events and filings do not provide specific details about the company's strategic initiatives or operational changes. The absence of recent transcripts or filings implies that the company may not have disclosed significant developments in the near term. Investors should monitor the company's future filings for any strategic shifts or operational updates.
- Athanase Innovation AB has a strong liquidity position with a current ratio of 6.03 and no long-term debt.
- The company's profitability is healthy, with a net income of 23.389 million SEK, but its ROE and ROA are below industry medians.
- The company's revenue is not segmented, and its geographic exposure is not disclosed, indicating a lack of diversification.
- Free cash flow of 26.72 million SEK provides the company with financial flexibility for reinvestment or shareholder returns.
- The company faces a medium liquidity risk due to negative operating cash flow and a low dilution risk.
Bull / Bear case
Generated · model-assistedThe company maintains a zero debt-to-equity ratio, significantly lower than the 0.04 cohort median, indicating a strong balance sheet.
Revenue demonstrated a 51.2% compound annual growth rate over the four-year period ending in the latest fiscal year.
The firm holds a tangible book value of 657.2 million SEK, providing a substantial equity base for operations.
Dilution and credit risks are assessed as low, suggesting manageable structural risks for long-term investors.
Return on equity of 3.56% places the company in the bottom quartile of its financial services peer group.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Athanase Innovation AB Market data — financials · 2026-05-27